Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9

Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9

US Patent 9724411 · Granted Aug 8, 2017

Estimated economic value: $380,434,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding proteins to the human thrombin receptor, PAR42025
Immunoglobulin proteins that bind to NPR1 agonists2025
Multispecific antigen-binding molecules and uses thereof2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Anti-PCSK9 antibodies2025
Anti-PCSK9 antibodies2025
Anti-PCSK9 antibodies2025
Anti-PCSK9 antibodies2025
Genetically modified mouse with a humanized PNPLA3 gene and methods of use2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
High affinity human antibodies to human IL-4 receptor2024
High affinity human antibodies to human IL-4 receptor2024